Invention Application
- Patent Title: Dipeptidyl Peptidase-IV Inhibitors
- Patent Title (中): 二肽基肽酶-IV抑制剂
-
Application No.: US13006363Application Date: 2011-01-13
-
Publication No.: US20110112051A1Publication Date: 2011-05-12
- Inventor: Heiko KROTH , Tim Feuerstein , Frank Richter , Jürgen Boer , Michael Essers , Bert Nolte , Matthias Schneider , Matthias Hochguertel , Fritz-Frieder Frickel , Arthur Taveras , Christoph Steeneck
- Applicant: Heiko KROTH , Tim Feuerstein , Frank Richter , Jürgen Boer , Michael Essers , Bert Nolte , Matthias Schneider , Matthias Hochguertel , Fritz-Frieder Frickel , Arthur Taveras , Christoph Steeneck
- Applicant Address: US CA Thousand Oaks
- Assignee: Alantos Pharmaceuticals Holding, Inc.
- Current Assignee: Alantos Pharmaceuticals Holding, Inc.
- Current Assignee Address: US CA Thousand Oaks
- Main IPC: A61K31/41
- IPC: A61K31/41 ; C07D403/12 ; C07D413/14 ; A61K31/5377 ; C07D403/14 ; C07D207/16 ; A61K31/40 ; C07F5/02 ; A61K31/69 ; C07D487/08 ; A61K31/407 ; C07D209/52 ; A61K31/403 ; A61K31/4196 ; C07D413/12 ; A61K31/4245 ; A61K31/496 ; C07D401/14 ; A61K31/4545 ; A61P3/10
Abstract:
The present invention relates generally to pyrrolidine and thiazolidine DPP-IV inhibitor compounds. The present invention also provides synthetic methods for preparation of such compounds, methods of inhibiting DPP-IV using such compounds and pharmaceutical formulations containing them for treatment of DPP-IV mediated diseases, in particular, Type-2 diabetes.
Public/Granted literature
- US08076330B2 Dipeptidyl peptidase-IV inhibitors Public/Granted day:2011-12-13
Information query
